A small shopping basket filled with vials labeled "COVID-19 - Coronavirus Vaccine" and medical syringes are placed on a US flag in this illustration photo.(REUTERS)
A small shopping basket filled with vials labeled "COVID-19 - Coronavirus Vaccine" and medical syringes are placed on a US flag in this illustration photo.(REUTERS)

Why has the US recorded the highest number of deaths due to Covid-19?

  • Why does the world's leading power have the highest death toll and what lessons are American health specialists learning from the past year?
AFP, Washington
PUBLISHED ON FEB 23, 2021 09:00 AM IST

The United States crossed the grim milestone of 500,000 deaths from Covid-19 on Monday, a year since announcing its first known death from the virus on February 29, 2020 in the Seattle area.

Why does the world's leading power have the highest death toll and what lessons are American health specialists learning from the past year?

Here, infectious disease experts Joseph Masci and Michele Halpern provide answers to some of the key questions.

Masci, 70, is one of the leaders of Elmhurst Hospital in Queens, which was at the heart of New York's epidemic.

Halpern is a specialist at the Montefiore hospital group in New Rochelle, a New York suburb where the epidemic arrived in force in February 2020.

- Why has the United States been hit so hard? -

Prior to this pandemic, the United States observed coronaviruses "from a distance," explained Masci.

"There was SARS in Canada but very little or none in this country. There was no MERS here at all," he said.

"There was a lot of preparation made for Ebola coming to the United States, and it never really did.

"Suddenly this (coronavirus) was a problem where the United States was the epicenter."

Masci said it was difficult to compare the United States with other countries.

"I think smaller countries that had structured health care services had a good chance of bringing things into play quickly.

"In a country like ours, with 50 independent states, and a huge landmass, with largely a private hospital system, it is always going to be difficult to get everybody on board with one particular set of strategies," he explained.

Masci added that Donald Trump's administration had a "haphazard approach", which did not help.

"The fact that hospitals were competing with each other to get personal protective equipment didn't make sense. They had to centralize all of that very quickly and they didn't.

"It was a struggle to try to deal with those obstacles that were put up," he said.

Masci and Halpern rue that mask-wearing was politicized.

"It's purely a health care issue," said Masci, adding that it is going to be difficult for the federal government to "reframe" that message.

Halpern insists that people should not see mask-wearing as "infringing" on their freedom.

"There are other things we do routinely that you could say infringe our liberties like wearing a seatbelt or running through a red light," she said.

According to the Johns Hopkins University tally, another 1,297 virus-related deaths were reported on Monday in the United States.

- What are the main lessons to be learned from the crisis? -

For Masci, the most important lesson was to learn how to reconfigure hospitals to make them able to cope with a sudden influx of patients.

"Now... instead of 12 hot ICU beds, you have to have 150. Where do you get them? Who do you staff on with? So now we've learned this lesson." he said.

Masci said the group of public hospitals of which Elmhurst is a part found strategies to distribute the burden among NYC's 11 public hospitals by transferring patients very quickly.

"We've turned from one hospital with 500 beds, to 11 hospitals with about 5,000 beds. It's worked very nicely."

More generally, Halpern says the pandemic has made everyone realize that "hospitals need resources."

"You have to invest in research, but you also have to invest in hospitals, in nursing homes. They have to have enough staff, they have to have the equipment that they need and the personnel has to be happy," she added.

The epidemic has also sharply exposed inequalities, not just in health care but also in housing, with Black and Latino communities dying in disproportionately high numbers.

"We have to look at housing, and how it can be better suited to handling future epidemics. There are others coming," said Masci.

- Will we still be wearing masks in December? -

Vaccines are rolling out but health experts are cautious due to uncertainties surrounding the British and South African variants of the virus.

Masci says that if the variant strains don't turn into a huge problem and once we've reached the point where 70-80 percent of the population is vaccinated then "there's a good chance" we won't wear masks anymore.

"(But) suppose these variant strains do take hold, become more of a problem, are vaccine resistant, and we're all closing schools and putting masks and locking down again in a few months, (then) it's a lot harder to say by December, 'We'll be out of the woods.'"

Halpern says it's reassuring that the second wave was largely controlled, in New York at least.

"I have hopes that the vaccines will be effective and will tamper future waves. But it's hard to be sure whether our vaccines will be effective in the longer term, or on new variants. I don't think anyone knows that.

"So we have to be prepared that we're in this for a while," she said.

In the long term, Masci says countries must not "fall into the trap" of forgetting about the pandemic once it has passed.

"It is unnerving to think that this came without warning. It's caused so much restructuring of everything.

"We have to have a more meticulous global search for new pathogens because we're living in a time now where there is no, 'Something is happening in Asia and it's not going to happen in America.'"

SHARE THIS ARTICLE ON
Close
A study by the University of Oxford shows AstraZeneca effective against Brazil variant.(AP)
A study by the University of Oxford shows AstraZeneca effective against Brazil variant.(AP)

Covid-19 pandemic: WHO warns against letting guard down

Agencies, Geneva
UPDATED ON MAR 07, 2021 05:37 AM IST
“Countries are going to lurch back into third and fourth surges if we’re not careful.” Mike Ryan, WHO’s top emergency expert, told an online briefing.
Close
In the second phase of the vaccination drive, 3,005,039 people over 60 years of age and 460,782 between 45 and 59 years with comorbidities have received their first dose of the vaccine.(Reuters)
In the second phase of the vaccination drive, 3,005,039 people over 60 years of age and 460,782 between 45 and 59 years with comorbidities have received their first dose of the vaccine.(Reuters)

Cumulative Covid-19 vaccinations cross 20-million mark: Government

By hindustantimes.com | Written by Srivatsan K C, New Delhi
PUBLISHED ON MAR 06, 2021 11:35 PM IST
India has administered 20,662,073 doses of the vaccine so far of which 6,972,859 healthcare workers have received the first dose and 3,522,671 have got the second dose.
Close
Indian Army personnel receives a dose of COVID-19 vaccine at a military hospital in Jabalpur. (PTI Photo)
Indian Army personnel receives a dose of COVID-19 vaccine at a military hospital in Jabalpur. (PTI Photo)

Army veterans to be vaccinated from next week. All you need to know

By hindustantimes.com | Edited by Shankhyaneel Sarkar, Hindustan Times, New Delhi
PUBLISHED ON MAR 06, 2021 11:28 PM IST
  • The government, when it launched its vaccination programme on January 16, ensured that army personnel involved in active duty also get vaccinated as the nation in its first phase had decided to inoculate healthcare workers as well as frontline workers.
Close
Researchers sequenced 750 genomes of the novel coronavirus from infected individuals and analysed mutations for their potential to alter T cell epitopes.(Reuters)
Researchers sequenced 750 genomes of the novel coronavirus from infected individuals and analysed mutations for their potential to alter T cell epitopes.(Reuters)

Study says some coronavirus mutations help it evade T-killer cells

PTI, London
UPDATED ON MAR 06, 2021 04:22 PM IST
In the current study, published in the journal Cell Immunology, the researchers sequenced 750 genomes of the novel coronavirus from infected individuals and analysed mutations for their potential to alter T cell epitopes.
Close
The researchers at the Georgia Institute of Technology and Emory University, US, used the technology to code for a protein called Cas13a that destroys parts of the RNA genetic code which viruses use to replicate in cells in the lungs.(HT Archive/For Representative Purposes Only)
The researchers at the Georgia Institute of Technology and Emory University, US, used the technology to code for a protein called Cas13a that destroys parts of the RNA genetic code which viruses use to replicate in cells in the lungs.(HT Archive/For Representative Purposes Only)

Treatment based on CRISPR can stop replication of Covid-19, flu viruses: Study

PTI, Washington
PUBLISHED ON MAR 05, 2021 04:34 PM IST
The therapy, described in the journal Nature Biotechnology, is based on CRISPR technology, which is normally used to target and edit specific portions of the genetic code -- the way that the four bases of DNA -- A, C, G and T -- are strung together.
Close
The study is the world's largest trial of treatments for hospitalised Covid-19 adults.(Reuters file photo. Representative image)
The study is the world's largest trial of treatments for hospitalised Covid-19 adults.(Reuters file photo. Representative image)

UK Covid-19 trial finds no benefit of gout drug in hospitalised adults

Posted by Harshit Sabarwal | Reuters
PUBLISHED ON MAR 05, 2021 04:06 PM IST
An independent panel suggested pausing recruitment of volunteers in the colchicine arm of the trial based on a preliminary analysis, scientists involved in UK's RECOVERY study said.
Close
The researchers said there is wide variation in how much antibody a person produces in response to vaccination or natural infection.(AP)
The researchers said there is wide variation in how much antibody a person produces in response to vaccination or natural infection.(AP)

Covid-19 antibodies, vaccines less effective against virus variants: Study

Posted by Harshit Sabarwal | PTI, Washington
PUBLISHED ON MAR 05, 2021 02:33 PM IST
The research, published in the journal Nature Medicine, noted that the three fast-spreading variants of the coronavirus first reported in South Africa, the UK and Brazil, can evade antibodies that work against the original form of the virus that sparked the pandemic.
Close
India’s vaccination drive has completed 17,711,287 jabs as of 7pm on Thursday.(HT Photo)
India’s vaccination drive has completed 17,711,287 jabs as of 7pm on Thursday.(HT Photo)

More than 1 million Covid-19 vaccine doses given in a day: Government

By hindustantimes.com | Written by Srivatsan K C, New Delhi
PUBLISHED ON MAR 04, 2021 11:16 PM IST
“Total 10,93,954 vaccine doses were given till 7 pm today, the forty-eighth day of nationwide COVID19 vaccination,” the health ministry said in a statement.
Close
South Africa regulator at 'advanced' stage of Pfizer's Covid-19 vaccine review (Reuters)
South Africa regulator at 'advanced' stage of Pfizer's Covid-19 vaccine review (Reuters)

South Africa regulator at 'advanced' stage of Pfizer Covid-19 vaccine review

Reuters
PUBLISHED ON MAR 04, 2021 10:46 PM IST
According to the South African Health Products Regulatory Authority (SAHPRA), Pfizer's Section 21 application is in advanced stages of review. Such an application, normally valid for six months, is an instrument for emergency use access of a health product that is unregistered.
Close
The isolates or viral samples were recovered from nasal secretions of consenting Covid-19 positive individuals.(Pixabay | Representational image)
The isolates or viral samples were recovered from nasal secretions of consenting Covid-19 positive individuals.(Pixabay | Representational image)

Indian study finds multiple mutations, unique proteins in coronavirus

PTI, Bengaluru
PUBLISHED ON MAR 04, 2021 04:36 PM IST
The study has also shown that the host produces several proteins of their own as their body launches an immunological defence in response to the viral attack.
Close
Canadian company Resverlogix has used the QIMR Berghofer research findings as the basis for expanding its clinical trial of the drug, apabetalone.(Representative image/Bloomberg)
Canadian company Resverlogix has used the QIMR Berghofer research findings as the basis for expanding its clinical trial of the drug, apabetalone.(Representative image/Bloomberg)

Researchers identify cause, potential treatment for Covid-induced heart damage

ANI, Washington
PUBLISHED ON MAR 04, 2021 05:09 AM IST
In severe cases of Covid-19, the immune system overreacts to the infection, releasing inflammatory molecules called cytokines into the bloodstream.
Close
Terezinha da Conceicao, 80, left, and Dulcinea da Silva Lopes, 59, get vaccinated in front of the Christ the Redeemer statue in Rio de Janeiro, Brazil. Data in recent weeks on new variants from South Africa and Brazil has undercut optimism sparked late last year by two vaccines with around 95% efficacy against Covid-19. (AP Photo)
Terezinha da Conceicao, 80, left, and Dulcinea da Silva Lopes, 59, get vaccinated in front of the Christ the Redeemer statue in Rio de Janeiro, Brazil. Data in recent weeks on new variants from South Africa and Brazil has undercut optimism sparked late last year by two vaccines with around 95% efficacy against Covid-19. (AP Photo)

Mutating Covid-19 mars optimism initially brought on by vaccines: Report

Reuters, Chicago
PUBLISHED ON MAR 03, 2021 11:12 PM IST
A new consensus is emerging among scientists, according to Reuters interviews with 18 specialists who closely track the pandemic or are working to curb its impact.
Close
PM Modi, President Kovind, Vice President Naidu, Union minister Harsh Vardhan and eminent Sarod player Ustad Amjad Ali Khan received their first does of Covid-19 vaccine. (HT Photos/Twitter/BeFunkyCollage)
PM Modi, President Kovind, Vice President Naidu, Union minister Harsh Vardhan and eminent Sarod player Ustad Amjad Ali Khan received their first does of Covid-19 vaccine. (HT Photos/Twitter/BeFunkyCollage)

Covid-19 vaccination drive: List of eminent personalities inoculated

By hindustantimes.com | Edited by Shankhyaneel Sarkar, Hindustan Times, New Delhi
UPDATED ON MAR 03, 2021 08:10 PM IST
  • These lawmakers are trying to address vaccine hesitancy which medical experts and lawmakers believe may impact the vaccination drive.
Close
Representational image. (Pratham Gokhale/HT Photo)
Representational image. (Pratham Gokhale/HT Photo)

Covaxin shows 81% efficacy in phase 3 clinical trial: Bharat Biotech

UPDATED ON MAR 04, 2021 03:44 AM IST
The vaccine is stable at 2°C to 8°C (refrigeration) and is shipped in a ready-to-use liquid formulation that permits distribution using existing vaccine supply chain channels
Close
A health worker holding up a Covaxin Covid-19 vaccine vial at Delhi Heart and Lung Institute in New Delhi. (Amal KS/ Hindustan Times)
A health worker holding up a Covaxin Covid-19 vaccine vial at Delhi Heart and Lung Institute in New Delhi. (Amal KS/ Hindustan Times)

Bharat Biotech releases Phase 3 results, says Covaxin has 81% efficacy rate

By hindustantimes.com | Edited by Shankhyaneel Sarkar, Hindustan Times, New Delhi
UPDATED ON MAR 03, 2021 07:53 PM IST
  • Interim clinical efficacy of India-made Covaxin is 81%, says Bharat Biotech
Close
SHARE
Story Saved
OPEN APP